Sanjeev Pandya, Executive Vice President for Global Business Development for Advanced Oncotherapy (AVO) provides an update to shareholders on development progress of the Company’s novel proton accelerator. Sanjeev also introduces Michel Baelen, the recently appointed Glob
al Head of Regulatory Affairs. Click the image to watch.